Research.Patient.info
Fragile X syndrome (FXS) research hub
3 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents, and Young Adults with Fragile X Syndrome - RECONNECT
This study is testing a CBD gel called ZYN002 for people with Fragile X syndrome. It aims to see if the gel can help with social avoidance and other behaviours in children, teenagers, and young adults.
Ireland - authorisedTherapeutic confirmatory (Phase III)
Cannabidiol (Epidyolex) for behavioural problems in patients with Tuberous Sclerosis Complex, Sanfilippo and Fragile X syndrome: an N-of-1 series
This study looks at how well a medicine called Epidyolex (which has CBD in it) helps with behaviour problems in people with particular conditions like Tuberous Sclerosis, Sanfilippo, and Fragile X syndrome. It checks if it improves things like irritability.
Netherlands - ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults with Fragile X Syndrome
Ireland